Showing results (621-630 of 832) with videos related to
Sort By:
Pageof 84
Investigative Ophthalmology & Visual Science|September 28, 2007
Oxidative stress is an early event in hydrostatic pressure induced retinal ganglion cell damageQuan Liu, Won-Kyu Ju, Jonathan G Crowston, et al.Journal of Neurochemistry|February 3, 2009
The essential role of ERK in 4-oxo-2-nonenal-mediated cytotoxicity in SH-SY5Y human neuroblastoma cellsHyun-Pil Lee, Xiaochun Zhu, Xiongwei Zhu, et al.Current Pharmaceutical Design|September 10, 2011
New insights into the mechanisms of mitochondrial preconditioning-triggered neuroprotectionSónia C Correia, Susana Cardoso, Renato X Santos, et al.Neurology|January 21, 2025
Association of Polygenic Risk Score for 5 Diseases With Alzheimer Disease Progression, Biomarkers, and Amyloid DepositionJingjing Liang, Sadiya Hussainy, Sara Michelle Lee, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 24, 2024
Associations of semaglutide with first-time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real-world data in the USWilliam Wang, QuangQiu Wang, Xin Qi, et al.International Journal of Clinical and Experimental Pathology|December 17, 2008
Evidence for the novel expression of human kallikrein-related peptidase 3, prostate-specific antigen, in the brainJeremy G Stone, Raj K Rolston, Masumi Ueda, et al.Journal of Biomedicine & Biotechnology|October 19, 2006
Targeting gonadotropins: an alternative option for Alzheimer disease treatmentGemma Casadesus, Emma Ramiro Puig, Kate M Webber, et al.Journal of Alzheimer'S Disease : JAD|July 9, 2009
Reexamining Alzheimer's disease: evidence for a protective role for amyloid-beta protein precursor and amyloid-betaRudy J Castellani, Hyoung-gon Lee, Sandra L Siedlak, et al.Neurochemical Research|March 8, 2007
Indices of metabolic dysfunction and oxidative stressGemma Casadesus, Paula I Moreira, Akihiko Nunomura, et al.Drugs in R&D|June 7, 2006
The estrogen myth: potential use of gonadotropin-releasing hormone agonists for the treatment of Alzheimer's diseaseGemma Casadesus, Matthew R Garrett, Kate M Webber, et al.Pageof 84